Skip to Content

Ceapro Inc CRPOF Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 0.28
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 0.27  –  0.28
  • Year Range 0.25  –  0.60
  • Market Cap 21.5306 Mil
  • Volume / Avg 121,770.0 /  10,046.8
  • Price / Sales 2.31
  • Price / Book 0.92
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CRPOF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CRPOF

Company Profile CRPOF

Business Description

Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

7824-51 Avenue NW
Edmonton, AB, T6E 6W2, CAN
Industry Biotechnology

Competitors & Peers CRPOF

Morningstar does not cover competitors or peers for this firm.

FAQs for Ceapro Inc Stock

No. CRPOF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CRPOF’s market cap is 21.53 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CRPOF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CRPOF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CRPOF’s historical performance against its industry peers and the overall market.